Because obesity is a risk factor for renal cell cancer (Calle and Kaaks, 2004), and diabetics are at higher risk than those without diabetes (Wideroff et al, 1997; Lindblad et al, 1999), it is possible that improved insulin sensitivity lowers renal cell cancer risk. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.